- Home
- NTZ vs DXR Comparison
NTZ vs DXR Comparison
Compare NTZ & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTZ
- DXR
- Stock Information
- Founded
- NTZ 1959
- DXR 1970
- Country
- NTZ Italy
- DXR United States
- Employees
- NTZ N/A
- DXR N/A
- Industry
- NTZ Home Furnishings
- DXR Medical/Dental Instruments
- Sector
- NTZ Consumer Discretionary
- DXR Health Care
- Exchange
- NTZ Nasdaq
- DXR Nasdaq
- Market Cap
- NTZ 39.0M
- DXR 36.4M
- IPO Year
- NTZ 1993
- DXR N/A
- Fundamental
- Price
- NTZ $3.51
- DXR $9.29
- Analyst Decision
- NTZ
- DXR Strong Buy
- Analyst Count
- NTZ 0
- DXR 1
- Target Price
- NTZ N/A
- DXR $25.00
- AVG Volume (30 Days)
- NTZ 4.0K
- DXR 3.1K
- Earning Date
- NTZ 06-27-2025
- DXR 01-01-0001
- Dividend Yield
- NTZ N/A
- DXR N/A
- EPS Growth
- NTZ N/A
- DXR 86.16
- EPS
- NTZ N/A
- DXR 0.11
- Revenue
- NTZ $330,051,765.00
- DXR $119,714.00
- Revenue This Year
- NTZ N/A
- DXR N/A
- Revenue Next Year
- NTZ N/A
- DXR N/A
- P/E Ratio
- NTZ N/A
- DXR $85.47
- Revenue Growth
- NTZ N/A
- DXR N/A
- 52 Week Low
- NTZ $3.07
- DXR $6.55
- 52 Week High
- NTZ $6.27
- DXR $10.00
- Technical
- Relative Strength Index (RSI)
- NTZ 38.10
- DXR 67.05
- Support Level
- NTZ $3.51
- DXR $8.45
- Resistance Level
- NTZ $4.40
- DXR $9.03
- Average True Range (ATR)
- NTZ 0.08
- DXR 0.35
- MACD
- NTZ -0.06
- DXR 0.02
- Stochastic Oscillator
- NTZ 0.00
- DXR 90.31
About NTZ Natuzzi S.p.A.
Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.